FLT1 and neoplasm: It exhibits potent in vitro inhibitory activity against VEGFR-1 and VEGFR-2 tyrosine kinases by blocking VEGFR-1 signaling which inhibits pathological angiogenesis associated with cancer and tumor metastasis.